📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picksUnlock AI Picks

Gossamer Bio Inc (GOSS)

NASDAQ
Currency in USD
Disclaimer
0.926
+0.028(+3.08%)
Real-time Data
GOSS Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.8720.938
52 wk Range
0.4531.600
Prev. Close
0.899
Open
0.9
Day's Range
0.872-0.938
52 wk Range
0.453-1.6
Volume
409,484
Average Volume (3m)
1,746,045
1-Year Change
-4.67%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
GOSS Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
6.719
Upside
+625.594%
Members' Sentiments
Bearish
Bullish
ProTips
7 analysts have revised their earnings upwards for the upcoming period
Show more

Gossamer Bio Inc Company Profile

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Compare GOSS to Peers and Sector

Metrics to compare
GOSS
Peers
Sector
Relationship
P/E Ratio
−2.6x−2.7x−0.6x
PEG Ratio
−0.03−0.040.00
Price/Book
2.6x3.7x2.6x
Price / LTM Sales
2.2x8.9x3.1x
Upside (Analyst Target)
678.6%227.3%57.2%
Fair Value Upside
Unlock12.9%7.3%Unlock

FAQ

What Is the Gossamer Bio (GOSS) Stock Price Today?

The Gossamer Bio stock price today is 0.926

What Stock Exchange Does Gossamer Bio Trade On?

Gossamer Bio is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Gossamer Bio?

The stock symbol for Gossamer Bio is "GOSS."

What Is the Gossamer Bio Market Cap?

As of today, Gossamer Bio market cap is 207.45M.

What is Gossamer Bio Earnings Per Share?

The Gossamer Bio EPS is -0.371.

What Is the Next Gossamer Bio Earnings Date?

Gossamer Bio will release its next earnings report on 11 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.